Skip to content
Sign in
SWC 2026 FinalistGrand Final: Main Stage

Chonex

Alabama agtech turning black soldier fly chitin into patented biostimulants and biopesticides, backed by 550+ field trials.

Birmingham (Alabama) – production site in Robertsdale (Baldwin County, Alabama), United States, North AmericaAgri & FoodTech, Agricultural inputs from black soldier fliesConvergeSouth 2026 (Winston-Salem, North Carolina)
Stage
SeedNo documented AI
Product
On the marketFirst customers
Funding raised
$10Mdisclosed
Founded
20179 years ago
Founders
1Michael
Global score
5.3Grade CRank 28 of 151

Overview

CHONEX produces natural insect-derived agricultural inputs (black soldier fly larvae) to improve soil health, manage disease pressure and protect yield.

Traction

First customers

First commercial product (StrongSoil biofertilizer, patent granted); 550+ field trials and grower testimonials (blueberries, citrus, grapes).

Market

Biostimulants and biofertilizers

Growers buy biostimulants and biopesticides to improve soil health and manage disease as chemical inputs face regulation and residue limits. Specialty crops (berries, citrus, grapes) adopt first because value per acre is high. Products move through ag retailers and distributors, and adoption hinges on local field-trial results. The category is fragmented and growing.

Addressable market

2025
$4.5B
2030
$7.8B
+11.9% a year

Biostimulants and biofertilizers: $4.46bn in 2025, 11.9% CAGR (MarketsandMarkets).

Customers

Specialty-crop growers (blueberries, citrus, grapes), then row crops; distributors and ag retailers

Who signs the cheque

Growers and crop advisers; ag-retail distributors

Geographies

  • United States

Drivers

  • Regulation and residue limits on synthetic chemistry
  • Soil-health and regenerative practices
  • Circular economy for poultry litter and waste

Headwinds

  • Slow agricultural adoption
  • Biostimulant competition
  • Scaling insect production

MarketsandMarkets estimates biostimulants at $4.46bn in 2025 and $7.84bn in 2030 (11.9% CAGR); Fortune $4.54bn, GMI $4.6bn.

Scalability 5/10. Exportable biological input, but fertilizer registration country by country and physical insect production.

Market source: marketsandmarkets.com

Technology

Category

Ag biologicals (insect-derived)

No documented AI

Maturity

  1. R&D
  2. Prototype
  3. Pilot
  4. On the market
  5. Scaling

in market

How it works

Black soldier fly larvae convert poultry litter and waste; their chitin/chitosan is turned into biostimulants and biopesticides. The first product, StrongSoil biofertilizer, has a granted patent.

Moat

Granted patent, 550+ field trials and production know-how give solid defensibility in its niche.

Differentiation

Chitin-based dual function (soil health plus disease pressure) from a circular feedstock.

Integration points

  • RNAi or other bio-pesticides
  • Farm management platforms
  • Regenerative farming programmes
  • International BSF processors

Depends on

  • Insect rearing scale
  • State fertiliser registrations
  • EPA registration for biopesticide claims

Use of AI

No use of AI mentioned

Product in detail

Converting insect biomaterials (chitin/chitosan from black soldier fly larvae) into biostimulants and biopesticides.

Business

Model
Product sales of biological inputs to growers via distribution.
Revenue logic
Per-acre/per-ton input pricing; not disclosed.
Go-to-market
Field trials and grower testimonials feeding distributor sales in the US Southeast.

Next milestones

  1. Close of the $6M Series A
  2. Distribution agreement with a national ag retailer
  3. Second product (biopesticide) registration

Key risks

  • Adoption speed
  • Competition
  • Capex for production

Opportunities

4 found in the network

Concrete moves for Chonex inside the network: who to sell to, sell through, build with or raise from, each with the reasoning, the evidence and the first step.

  • Distribution 1
  • Market entry 1
  • Co-development 1
  • Investors 1

Distribution1

A channel or customer base to reach together

Bundle Chonex inputs into Regenrate's agronomic package

Regenrate provides seeds and agronomic support to hundreds of French farms under contract. If EU registration is feasible, Chonex inputs could be included in that package.

15%confidence

Evidence from the records

  • “free certified seeds, purchase price set before sowing, agronomic support”
  • “to improve soil health, manage disease pressure and protect yield”
If it works
A European test market via contracted farms.
First step
Check EU regulatory requirements before proposing a trial to Regenrate.

Market entry1

A local partner where they want to go

License the chitin formulation to a Sarawak BSF operator

NEX already runs a 20 t/day BSF bioconversion plant producing biofertilisers. Licensing Chonex's patented formulation gives NEX a higher-value product and Chonex a Southeast Asian palm and fruit market without capex.

30%confidence

Evidence from the records

  • “Circular biorefinery based on black soldier fly bioconversion (processing capacity of 20 t/day).”
  • “First commercial product (StrongSoil biofertilizer, patent granted)”
If it works
Royalty income and an Asian market entry.
First step
Send NEX a licensing term sheet outline and request their product specs.

Co-development1

An integration or joint product

Co-formulate chitin with RNAi biopesticides

Yeast Bay Bio's platform delivers RNAi against insect pests; Chonex has field-trial infrastructure and grower relationships. A combined biological programme can reach growers faster than either alone.

30%confidence

Evidence from the records

  • “Saccharomyces cerevisiae used as an RNAi vector; modular platform extended to other pest species by changing the RNA sequence.”
  • “550+ field trials and grower testimonials (blueberries, citrus, grapes)”
If it works
A joint biological crop-protection programme and trial data for Yeast Bay Bio.
First step
Discuss with Yeast Bay Bio which crop pests could be targeted in Chonex's trial crops.

Investors1

A fund whose thesis fits

Bring an agri CVC into the Series A

Cavallo Ventures is an agri-focused CVC investing from seed to Series B and backed network member ZymoChem. A strategic agri investor fits Chonex's $6M Series A and can accelerate distribution.

40%confidence

Evidence from the records

  • “Series A”
  • “$6M (closing)”
  • “Agri & FoodTech”
If it works
Strategic capital with distribution relevance.
First step
Ask ZymoChem's founders for an introduction to Cavallo.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Investors that fit

Wilbur-Ellis's stage-agnostic CVC backing agribusiness software, soil health, food ingredients and animal nutrition, with distribution through Wilbur-Ellis.

StrongSoil biofertilizer (patent granted) with 550+ field trials in blueberries, citrus and grapes: soil-health input ready for distributor channels.

65%confidence

Evidence from the records

  • “agribusiness software and soil health”
  • “Agricultural inputs from black soldier flies”
  • “550+ field trials”
Intro path
ZymoChem (Cavallo portfolio)
First step
Propose a Wilbur-Ellis distribution trial alongside a Series A conversation.

Pan-African climate-tech fund ($40M target) backing adaptation startups in agriculture, insurance, food, water and waste from pre-seed to Series A.

Black-soldier-fly biofertilizer improving soils: agri resilience, but US-based and already well funded.

10%confidence

Evidence from the records

  • “Agricultural inputs from black soldier flies”
  • “United States”
First step
Only with African production.

Investment analysis

5.3C

Grade C

Rank 28 of 151

Disruption6.0/10
Business model5.0/10
Market4.0/10
Risk(lower is better)5.0/10

Global score = mean of disruption, model, market and (11 − risk). Last updated 21 Nov 2026.

Solid agtech at an early commercial stage: speculative but credible.

Disruption

6/10

Agricultural inputs from soldier fly larvae: significant innovation in biostimulants.

Business model

5/10

First patented commercial product and 550+ field trials.

Market

4/10

Score 4/10: TAM $4.46bn → base 4; scalability 5/10 (0); no commercial presence in ≥2 countries yet (0).

Risk

5/10

Lower is better

Medium risk: $10M raised, gradual agricultural adoption.

Strengths

  • Patent and field trials
  • Significant funding

Risks

  • Slow agricultural adoption
  • Biostimulant competition

Funding

$10M, disclosed
  1. 2018-02

    prize (Alabama Launchpad)$85,000

    Alabama Launchpad (EDPA)

  2. 2018 (avant février)

    prize$10,000

    Birmingham Venture Club

  3. 2022

    seed$5.78M

    group of Alabama investors (Bhamwiki); VCBacked cites Southern Research, Jemison Investment Company

  4. 2023-01

    extension$2.5M

    not disclosed (Bhamwiki)

  5. 2024-12-04

    Seed II$3.45M

    not disclosed (CB Insights)

  6. 2026-03

    acceleratornot disclosed

    gener8tor (Caplight)

  7. 2026 (en cours)

    Series A$6M (closing)

    not disclosed

  8. non précisée

    Prosperity Fund support (Southern Research)not disclosed

    Prosperity Fund

Amount used in the study. CB Insights total of $9.98M (7 rounds, including $95K in prizes); sum of seed $5.78M + $2.5M + Seed II $3.45M as upper bound; Series A in progress excluded.

Note. Conflicting sources: $9.98M in 7 rounds (CB Insights); $4.35M (Caplight); ~$8.4M by adding the $5.78M seed (2022) + $2.5M (2023) + $95K in prizes (Bhamwiki); $6M Series A in progress

Business Alabama (Jan 2026) presents Chonex as a Robertsdale company whose plant (Baldwin County) converts poultry litter using soldier fly larvae; Caplight lists Vandiver (AL). The "$16M Series A BlackRock" headline seen on Caplight is an advertising banner from Caplight itself, not a Chonex round. $6M Series A not confirmed.

Team

  • Michael Lynch

    Founder & CEO

    Bioscience entrepreneur from Birmingham (Alabama) who turns poultry litter into organic fertilizer using the black soldier fly.

Sources

Regional final
ConvergeSouth 2026 (Winston-Salem, North Carolina)
Identification confidence
high
Founding year: 2017 (medium confidence)
Founded in 2017 by M. Lynch and H. Martin according to Bhamwiki; sp-edge and Bouncewatch indicate 2018 bhamwiki.com
  1. 1chonex.ag/chonex-wins-convergesouth-regional-pitch/
  2. 2caplight.com/company/chonex
  3. 3grepbeat.com/2026/08/31/startups-from-the-southeast-and-beyond-converge-
  4. 4agrimarketing.com/s/158029
  5. 5businessalabama.com/robertsdale-company-puts-flies-to-work-to-aid-regenerative-
  6. 6newswise.com/articles/with-prosperity-fund-help,-startup-chonex-aims-to-

From the open study Startup World Cup 2026 by TIBOK, based on public sources, verified in November 2026. Scores are an analyst's judgment on an explicit grid, not the jury's.

Wall

Wall

No posts yet